01-03-2000 | Articles
Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with Type II diabetes
Published in: Diabetologia | Issue 3/2000
Login to get access01-03-2000 | Articles
Published in: Diabetologia | Issue 3/2000
Login to get access